Portage Biotech Inc. (PRTG)
Portage Biotech Statistics
Share Statistics
Portage Biotech has 1.12M shares outstanding. The number of shares has increased by -94.33% in one year.
Shares Outstanding | 1.12M |
Shares Change (YoY) | -94.33% |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | 10.71% |
Shares Floating | 275.06K |
Failed to Deliver (FTD) Shares | 2.99K |
FTD / Avg. Volume | 0.49% |
Short Selling Information
The latest short interest is 10.04K, so 0.9% of the outstanding shares have been sold short.
Short Interest | 10.04K |
Short % of Shares Out | 0.9% |
Short % of Float | 1.36% |
Short Ratio (days to cover) | 0.17 |
Valuation Ratios
The PE ratio is -2.99 and the forward PE ratio is -9.04. Portage Biotech's PEG ratio is 0.07.
PE Ratio | -2.99 |
Forward PE | -9.04 |
PS Ratio | 0 |
Forward PS | 2.8 |
PB Ratio | 55.93 |
P/FCF Ratio | -15.74 |
PEG Ratio | 0.07 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Portage Biotech.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.67, with a Debt / Equity ratio of 0.01.
Current Ratio | 2.67 |
Quick Ratio | 2.67 |
Debt / Equity | 0.01 |
Debt / EBITDA | 0 |
Debt / FCF | 0 |
Interest Coverage | -570.41 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $0 |
Profits Per Employee | $-10.76M |
Employee Count | 7 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | -10.55M |
Effective Tax Rate | 12.31% |
Stock Price Statistics
The stock price has increased by -39.59% in the last 52 weeks. The beta is 0.97, so Portage Biotech's price volatility has been higher than the market average.
Beta | 0.97 |
52-Week Price Change | -39.59% |
50-Day Moving Average | 4.79 |
200-Day Moving Average | 4.73 |
Relative Strength Index (RSI) | 53.7 |
Average Volume (20 Days) | 616.09K |
Income Statement
Revenue | n/a |
Gross Profit | -54K |
Operating Income | -18.25M |
Net Income | -75.34M |
EBITDA | -18.2M |
EBIT | -18.25M |
Earnings Per Share (EPS) | -3.7 |
Balance Sheet
The company has 5.03M in cash and 47K in debt, giving a net cash position of 4.98M.
Cash & Cash Equivalents | 5.03M |
Total Debt | 47K |
Net Cash | 4.98M |
Retained Earnings | -239.32M |
Total Assets | 2.71M |
Working Capital | 1.81M |
Cash Flow
In the last 12 months, operating cash flow was -14.3M and capital expenditures 0, giving a free cash flow of -14.3M.
Operating Cash Flow | -14.3M |
Capital Expenditures | 0 |
Free Cash Flow | -14.3M |
FCF Per Share | -0.7 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
PRTG does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for PRTG.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Stock Splits
The last stock split was on Aug 15, 2024. It was a backward split with a ratio of 1:20.
Last Split Date | Aug 15, 2024 |
Split Type | backward |
Split Ratio | 1:20 |
Scores
Altman Z-Score | -216.7 |
Piotroski F-Score | 3 |